Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled study of rapid onset of tocilizumab in active rheumatoid arthritis
2008-008309-23Phase 4Completed
- Sponsor
- Roche
- Start
- Mar 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Tocilizumab with Placebo (2 arms). Primary endpoint: Clinically meaningful HAQ-DI improvement at 4 weeks. Started Mar 2009; status: completed.
02
Drugs
tocilizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2008-008309-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008309-23.